News search

E.g., 17/06/2024
E.g., 17/06/2024
RM cardiaca de un paciente con miocardiopatía dilatada (izquierda) y de un individuo sin cardiopatía (derecha). En el paciente con miocardiopatía dilatada el tamaño del corazón esta incrementado y su capacidad de bombeo está disminuida.
Research
19 Apr 2024
JACC: A new Spanish study provides the first stratification of the risk of developing dilated cardiomyopathy among symptom-free genetic carriers

The results, published in JACC, suggest that these factors could be used to predict the risk of developing dilated cardiomyopathy and adapt strategies for patient care and disease detection in genetic carriers of the disease

Agustín Clemente-Moragón, Borja Ibáñez, Anabel Díaz-Guerra, Laura Cádiz, Carlos Galán-Arriola, Miguel Fernández-Tocino, Mónica Gómez, Rocío Villena-Gutiérrez, y Eduardo Oliver.
Research
16 Apr 2024
JACC: CardioOncology: CNIC scientists identify therapeutic targets for the prevention of heart injury linked to cancer treatment

The study, published in the journal JACC: CardioOncology, identifies mitochondrial function and heart metabolism as targets for possible treatments to protect against anthracycline-induced cardiotoxicity
El Dr. Valentín Fuster con la Dra. Guiomar Mendieta
About the CNIC
10 Apr 2024
The Journal of the American College of Cardiology garlands the CNIC author of a PESA-CNIC-SANTANDER study

Guiomar Mendieta has been awarded the 2023 William W. Parmley Young Author Achievement Award for a paper published in JACC that is considered to an outstanding contribution in the field of atherosclerosis
Representative results from participants showing atherosclerosis progression (left) and regression (disappearance of plaques, right) in arteries of the neck (carotids) and groin (femorals). Each image pair shows the results of the initial study at baseline and the follow-up study of the same artery 6 years later. The images show representative vascular ultrasound images on the right and 3-dimensional reconstructions on the left.
Research
20 Nov 2023
JACC: Younger people are more vulnerable to the effects of cardiovascular risk associated with high blood cholesterol and hypertension

Atherosclerosis, previously believed to be an irreversible progressive disease, can be reversed if risk factors are contolled early enough
Dr. Fuster
Research
6 Mar 2023
JACC: High-Dose Anticoagulation Can Reduce Intubations and Improve Survival for Hospitalized COVID-19 Patients

A study could change management of patients who are not critically ill
Pablo García Pavía and Luis Escobar
Research
12 Sep 2022
JACC: Scientists at the CNIC and Hospital Puerta de Hierro develop a tool to determine if dilated cardiomyopathy has a genetic origin

The findings, published in the Journal of the American College of Cardiology (JACC), will enable physicians to make appropriate treatment adjustments for patients with this disease
Fernando de Frutos y el Dr. Pablo García Pavía.
Research
29 Aug 2022
JACC: CNIC scientists describe key features of one of the most frequent forms of hereditary dilated cardiomyopathy

The findings, published in the Journal of the American College of Cardiology (JACC), represent a first step towards the personalized treatment of patients with this disease
Valentín Fuster
About the CNIC
4 Apr 2022
Prestigious Award Named in Honor of Valentin Fuster, During American College of Cardiology Scientific Session

CNIC leader will be recognized for his exceptional achievements at the 71st annual conference
. 3D model of a femoral artery obtained by real 3D imaging, revealing the location, number, and extent of distinct atherosclerotic plaques. In this sample, three plaques can be discerned (arrows), at the femoral bifurcation and distributed along the superficial branch.
Research
16 Mar 2022
JACC: 3D matrix ultrasound accurately identifies cardiovascular injury in healthy individuals

Scientists at the CNIC have led the development of a new three dimensional ultrasound method that improves the assessment of cardiovascular risk in healthy individuals
Research
30 Aug 2021
JACC: A drug costing less than €2 a day helps in the treatment of severely ill COVID-19 patients

The safety, availability, and robust biological effect of metoprolol could together be enough to consider its use in young patients admitted to the ICU with severe COVID-19